Submit Manuscript    >>    Login | Register

AF Literature Database


Search Knowledgebase by



Author last name starts with
B. Weijs(4)Asirvatham Samuel J SJ(3)Alan S. Go, MD(3)
Charlotte Eitel, MD(3)Ayman A. Hussein, MD(3)Chamberlain AM(2)
Berenfeld Omer O(2)Caputo M(2)Chao TF(2)
Chen Peng-Sheng PS(2)Albert Nancy M NM(2)Andrade JG(2)
Akira Fukui, MD(2)Ajay K Jain(2)Cook G Elliott GE(2)
Botto GL(2)Bokeriia L A LA(2)Casella M(2)
Antonio Hernández-Madrid(2)Christian Sohns(2)Bengt Zöller(2)
Badger Troy J TJ(2)Charlotte Eitel(2)Blanke Philipp P(2)
Anné Wim W(2)Cortez-Dias Nuno N(1)Babuty D D(1)
Clem James R JR(1)Castellá Manuel M(1)Abdo Ashraf S AS(1)
Corino Valentina D A VD(1)Aref A. Bin Abdulhak(1)Boll Stefanie S(1)
Badge Ravi R(1)Burashnikov Alexander A(1)Cohen-Lehman Janna J(1)
Chamorro A A(1)Andrikopoulos G(1)cas V.A. Boersma, MD, PhD(1)
Aakriti Gupta(1)Creswell Lawrence L LL(1)Chung Tommy T(1)
Benussi Stefano S(1)Crotti Lia L(1)Cao H(1)
Clare Teresa Oliver-Williams(1)Alsheikh-Ali Alawi A AA(1)Copie X X(1)
Biffi Mauro M(1)Bhuriya Rohit R(1)


Literature Related to Hugo A. Katus, MD [Author]
1
  • Connexin 43 gene therapy prevents persistent atrial fibrillation in a porcine model


    Authors : Bikou O; Thomas D; Trappe K; Lugenbiel P; Kelemen K; Koch M; Soucek R; Voss F; Becker R; Katus HA;

    Affiliations : Department of Cardiology, Medical University Hospital, Im Neuenheimer Feld 410, Heidelberg D-69120, Germany. Tel: +49 6221 568855; fax: +49 6221 565514, Email: olympia.bikou@med.uni-heidelberg.de; dierk.thomas@med.uni-heidelberg.de

    Journal : Eurpopace   (2011 )

    Related Links: Pubmed | Publisher website


  • Biomarkers in relation to the effects of ticagrelor in comparison with clopidogrel in non-ST-elevation acute coronary syndrome patients managed with or without in-hospital revascularization: a substudy from the Prospective Randomized Platelet Inhibition a


    Authors : Daniel Lindholm, MD; Agneta Siegbahn, MD, PhD; Lisa Wernroth, MSc; Richard C. Becker, MD; Christopher P. Cannon, MD; Jan H. Cornel, MD, PhD; Anders Himmelmann, MD, PhD; Evangelos Giannitsis, MD; Robert A. Harrington, MD; Claes Held, MD, PhD; Steen Husted, MD, DSc; Hugo A. Katus, MD; Kenneth W. Mahaffey, MD; Ph. Gabriel Steg, MD; Robert F. Storey, MD, DM; Stefan K. James, MD, PhD;

    Affiliations : Department of Medical Sciences, Cardiology and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden (L.W., D.L., L.W., C.H., S.K.J.); Department of Medical Sciences, Clinical Chemistry and Uppsala Clinical Research Center Uppsala University, Uppsala, Sweden (A.S.); Division of Cardiovascular Health and Disease, Heart, Lung and Vascular Institute, Academic Health Center, Cincinnati, OH (R.C.B.); Department of Medicine, Stanford University, Stanford, CA (R.A.H., K.W.M.); TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, MA (C.P.C.); Department of Cardiology, Medisch Centrum Alkmaar, Alkmaar, Netherlands (J.H.C.); AstraZeneca Research and Development, Mölndal, Sweden (A.H.); Medizinische Klinik, Universitätsklinikum Heidelberg, Heidelberg, Germany (E.G., H.A.K.); Medical Department, Hospital Unit West, Herning/Holstbro, Denmark (S.H.); INSERM-Unité 698, Paris, France; Assistance Publique-Hôpitaux de Paris, Département Hospitalo-Universitaire FIRE, Hôpital Bichat, Paris, France; Université Paris-Diderot, Sorbonne-Paris Cité, Paris, France; NHLI Imperial College, ICMS, Royal Brompton Hospital, London, UK (P.G.S.); and Department of Cardiovascular Science, University of Sheffield, Sheffield, UK (R.F.S.).

    Journal : N/A   (2014)

    Related Links: Pubmed | Publisher website



Biosense Webster
event date
Introduction to AFib
Ablation Specialist

View Ablation Specialists